Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam and brensocatib drug-drug interaction study
NL-OMON61650Phase 1Recruiting
- Sponsor
- Insmed Incorporated
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of brensocatib and midazolam in bronchiectasis, sponsored by Insmed Incorporated. Primary endpoint: Primary endpoint(s). Started Oct 2026; status: recruiting.
02
Drugs
brensocatibmidazolam
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NL-OMON61650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61650.